Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.

Dimitriu-Leen AC, Gimelli A, Al Younis I, Veltman CE, Verberne HJ, Wolterbeek R, Zandbergen-Harlaar S, Bax JJ, Scholte AJ.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):326-32. doi: 10.1007/s00259-015-3220-5. Epub 2015 Oct 29.

2.

Impairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study.

Prunet B, Basely M, D'Aranda E, Cambefort P, Pons F, Cimarelli S, Dagain A, Desse N, Veyrieres JB, Jego C, Lacroix G, Esnault P, Boret H, Goutorbe P, Bussy E, Habib G, Meaudre E.

Crit Care. 2014 Jun 25;18(3):R131. doi: 10.1186/cc13943.

3.

The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy.

Klein T, Dilsizian V, Cao Q, Chen W, Dickfeld TM.

Curr Cardiol Rep. 2013 May;15(5):359. doi: 10.1007/s11886-013-0359-1. Review.

4.

Synthesis and bioevaluation of [(18)F]4-fluoro-m-hydroxyphenethylguanidine ([(18)F]4F-MHPG): a novel radiotracer for quantitative PET studies of cardiac sympathetic innervation.

Jang KS, Jung YW, Sherman PS, Quesada CA, Gu G, Raffel DM.

Bioorg Med Chem Lett. 2013 Mar 15;23(6):1612-6. doi: 10.1016/j.bmcl.2013.01.106. Epub 2013 Jan 30.

5.

Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Thackeray JT, Beanlands RS, Dasilva JN.

Am J Nucl Med Mol Imaging. 2012;2(3):314-34. Epub 2012 Jul 20.

6.

Cardiac autonomic nervous system in heart failure: imaging technique and clinical implications.

J Boogers M, E Veltman C, J Bax J.

Curr Cardiol Rev. 2011 Feb;7(1):35-42. doi: 10.2174/157340311795677725.

7.

The evolving roles of nuclear cardiology.

De Lorenzo A.

Curr Cardiol Rev. 2009 Jan;5(1):52-5. doi: 10.2174/157340309787048112.

8.

Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors.

Raffel DM, Jung YW, Gildersleeve DL, Sherman PS, Moskwa JJ, Tluczek LJ, Chen W.

J Med Chem. 2007 May 3;50(9):2078-88. Epub 2007 Apr 10.

9.
10.
11.

Regional distribution and kinetics of [18F]6-flurodopamine as a measure of cardiac sympathetic activity in humans.

Coates G, Chirakal R, Fallen EL, Firnau G, Garnett ES, Kamath MV, Scheffel A, Nahmias C.

Heart. 1996 Jan;75(1):29-34.

Supplemental Content

Support Center